Resistance to Targeted Therapies in Breast Cancer

Resistance to Targeted Therapies in Breast Cancer

We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast can...

Full description

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Prosperi, Jenifer R. (Editor)
Format: Electronic eBook
Language:English
Published: Cham : Springer International Publishing : Imprint: Springer, 2017.
Series:Resistance to Targeted Anti-Cancer Therapeutics, 16
Subjects:
Medicine.
Cancer research.
Biomedicine.
Cancer Research.
Online Access:Full Text via HEAL-Link

Internet

Full Text via HEAL-Link

ΒΚΠ - Πατρα: ALFd

Holdings details from ΒΚΠ - Πατρα: ALFd
Call Number: 330.01 BAU
Copy 1 Available

ΒΚΠ - Πατρα: BSC

Holdings details from ΒΚΠ - Πατρα: BSC
Call Number: 330.01 BAU
Copy 2 Available
Copy 3 Available

Similar Items